BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25425197)

  • 41. Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells.
    Tabe Y; Jin L; Tsutsumi-Ishii Y; Xu Y; McQueen T; Priebe W; Mills GB; Ohsaka A; Nagaoka I; Andreeff M; Konopleva M
    Cancer Res; 2007 Jan; 67(2):684-94. PubMed ID: 17234779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt.
    He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y
    Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells.
    Dozza B; Smith MA; Perry G; Tabaton M; Strocchi P
    J Neurochem; 2004 Jun; 89(5):1224-32. PubMed ID: 15147515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types.
    D'Agaro T; Bittolo T; Bravin V; Dal Bo M; Pozzo F; Bulian P; Rossi FM; Zucchetto A; Degan M; D'Arena G; Chiarenza A; Zaja F; Pozzato G; Di Raimondo F; Rossi D; Gaidano G; Del Poeta G; Gattei V; Bomben R
    Br J Haematol; 2018 Aug; 182(4):597-602. PubMed ID: 28699643
    [No Abstract]   [Full Text] [Related]  

  • 45. Ceramide 1-phosphate stimulates macrophage proliferation through activation of the PI3-kinase/PKB, JNK and ERK1/2 pathways.
    Gangoiti P; Granado MH; Wang SW; Kong JY; Steinbrecher UP; Gómez-Muñoz A
    Cell Signal; 2008 Apr; 20(4):726-36. PubMed ID: 18234473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-talk between the CK2 and AKT signaling pathways in cancer.
    Ruzzene M; Bertacchini J; Toker A; Marmiroli S
    Adv Biol Regul; 2017 May; 64():1-8. PubMed ID: 28373060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
    Lionetti M; Fabris S; Cutrona G; Agnelli L; Ciardullo C; Matis S; Ciceri G; Colombo M; Maura F; Mosca L; Gentile M; Recchia AG; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Rossi D; Gaidano G; Morabito F; Ferrarini M; Neri A
    Br J Haematol; 2014 Jun; 165(5):629-39. PubMed ID: 24579978
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of Notch1 signaling by the APP intracellular domain facilitates degradation of the Notch1 intracellular domain and RBP-Jk.
    Kim MY; Mo JS; Ann EJ; Yoon JH; Jung J; Choi YH; Kim SM; Kim HY; Ahn JS; Kim H; Kim K; Hoe HS; Park HS
    J Cell Sci; 2011 Jun; 124(Pt 11):1831-43. PubMed ID: 21558417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 2,3,5-Trisubstituted pyridines as selective AKT inhibitors. Part II: Improved drug-like properties and kinase selectivity from azaindazoles.
    Lin H; Yamashita DS; Zeng J; Xie R; Verma S; Luengo JI; Rhodes N; Zhang S; Robell KA; Choudhry AE; Lai Z; Kumar R; Minthorn EA; Brown KK; Heerding DA
    Bioorg Med Chem Lett; 2010 Jan; 20(2):679-83. PubMed ID: 20005102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients.
    Lionetti M; Barbieri M; Favasuli V; Taiana E; Fabris S; Favoino C; Ciceri G; Matis S; Colombo M; Massara R; Reda G; Gentile M; Spina V; Rossi D; Baldini L; Gaidano G; Fais F; Ferrarini M; Morabito F; Cutrona G; Neri A
    Hematol Oncol; 2020 Aug; 38(3):406-408. PubMed ID: 32097987
    [No Abstract]   [Full Text] [Related]  

  • 51. Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22.
    Arruga F; Gizdic B; Bologna C; Cignetto S; Buonincontri R; Serra S; Vaisitti T; Gizzi K; Vitale N; Garaffo G; Mereu E; Diop F; Neri F; Incarnato D; Coscia M; Allan J; Piva R; Oliviero S; Furman RR; Rossi D; Gaidano G; Deaglio S
    Leukemia; 2017 Sep; 31(9):1882-1893. PubMed ID: 28017968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.
    Baudot AD; Jeandel PY; Mouska X; Maurer U; Tartare-Deckert S; Raynaud SD; Cassuto JP; Ticchioni M; Deckert M
    Oncogene; 2009 Sep; 28(37):3261-73. PubMed ID: 19581935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation.
    Pozzo F; Bittolo T; Arruga F; Bulian P; Macor P; Tissino E; Gizdic B; Rossi FM; Bomben R; Zucchetto A; Benedetti D; Degan M; D'Arena G; Chiarenza A; Zaja F; Pozzato G; Rossi D; Gaidano G; Del Poeta G; Deaglio S; Gattei V; Dal Bo M
    Leukemia; 2016 Jan; 30(1):182-9. PubMed ID: 26165233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential regulation of cytokine production by PI3Kdelta in human monocytes upon acute and chronic inflammatory conditions.
    Molnarfi N; Brandt KJ; Gruaz L; Dayer JM; Burger D
    Mol Immunol; 2008 Jul; 45(12):3419-27. PubMed ID: 18471882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. H2O2-induced phosphorylation of ERK1/2 and PKB requires tyrosine kinase activity of insulin receptor and c-Src.
    Mehdi MZ; Pandey NR; Pandey SK; Srivastava AK
    Antioxid Redox Signal; 2005; 7(7-8):1014-20. PubMed ID: 15998256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.
    Liu ZJ; Xiao M; Balint K; Smalley KS; Brafford P; Qiu R; Pinnix CC; Li X; Herlyn M
    Cancer Res; 2006 Apr; 66(8):4182-90. PubMed ID: 16618740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia.
    Del Poeta G; Dal Bo M; Del Principe MI; Pozzo F; Rossi FM; Zucchetto A; Bomben R; Degan M; Rasi S; Rossi D; Bulian P; Gaidano G; Amadori S; Gattei V
    Br J Haematol; 2013 Feb; 160(3):415-8. PubMed ID: 23167503
    [No Abstract]   [Full Text] [Related]  

  • 58. A Novel Assay for the Identification of NOTCH1 PEST Domain Mutations in Chronic Lymphocytic Leukemia.
    Campregher PV; Petroni RC; Muto NH; Sitnik R; de Carvalho FP; Bacal NS; Velloso ED; Oliveira GB; Pinho JR; Torres DC; Mansur MB; Hassan R; Lorand-Metze IG; Chiattone CS; Hamerschlak N; Mangueira CL
    Biomed Res Int; 2016; 2016():4247908. PubMed ID: 28074183
    [No Abstract]   [Full Text] [Related]  

  • 59. Decreased apoptosis in polyamine depleted IEC-6 cells depends on Akt-mediated NF-kappaB activation but not GSK3beta activity.
    Bhattacharya S; Ray RM; Johnson LR
    Apoptosis; 2005 Aug; 10(4):759-76. PubMed ID: 16133867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations in the 3' untranslated region of
    Bittolo T; Pozzo F; Bomben R; D'Agaro T; Bravin V; Bulian P; Rossi FM; Zucchetto A; Degan M; Macor P; D'Arena G; Chiarenza A; Zaja F; Pozzato G; Di Raimondo F; Rossi D; Gaidano G; Del Poeta G; Gattei V; Dal Bo M
    Haematologica; 2017 Aug; 102(8):e305-e309. PubMed ID: 28550186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.